Akron Biotechnology, LLC Named 2014 Florida Companies to Watch Winner

 

Award Presented by GrowFL, in Association with the Edward Lowe FoundationHonors Upcoming Second-Stage Businesses throughout Florida

Akron Biotechnology, LLC (Akron Biotech) is proud to be selected as one of fifty leading second-stage companies selected from more than 500 nominations statewide, as this year’s Florida Companies to WatchSM winners. All 2014 winners will join an esteemed group of 150 Florida alumni honored over the past three years.

Florida Companies to Watch is an awards program that celebrates privately held second-stage companies headquartered in the state. To be eligible, applicants must employ between 6 and 99 full-time equivalent employees and have between $750,000 and $50 million in annual revenue or working capital in place. Awardees are selected for demonstrating the intent and capacity to grow based on employee or sales growth, exceptional entrepreneurial leadership, sustainable competitive advantage, outstanding corporate culture, inspired community giving and other notable strengths.

Florida Companies to Watch is honored to recognize another outstanding group of stage-two companies,” said Dr. Tom O’Neal, executive director of the Florida Economic Gardening Institute and associate vice president for the University of Central Florida’s Office of Research and Commercialization. This is our fourth year of celebrating second-stage business leaders throughout the state of Florida. The companies selected for the Florida Companies to Watch awards program stand out among their peers as companies that should be celebrated. In Florida, they account for 5 percent of the companies and nearly 30 percent of the jobs. These companies make a difference and we’re happy to offer the recognition they deserve.”

“We are very excited to have been honored as one of the 50 Florida Companies to Watch. This is a very important milestone in the life of our company. Our entire team, including consultants and suppliers, are dedicated to providing our valued customers with comprehensive solutions to meet their specific needs while providing quality products and unparalleled customer service. This commitment has resulted in consistent growth making Akron a key player in the regenerative medicine/biotechnology arena,” said Claudia Zylberberg, PhD., Founder and CEO of Akron Biotech.

About Akron Biotech

As an ISO certified global supplier, Akron Biotech manufactures ancillary materials and provides novel technologies for cell therapy discovery, development, and commercialization, meeting the industry’s quality standards worldwide. Akron Biotech has a strategic focus on delivering biological materials, technologies, and services for the regenerative medicine industry. Website: akronbiotech.com

About GrowFL:

GrowFL was created in 2009 by the Florida legislature as an economic development program focused on assisting second-stage growth companies prosper in the state of Florida. By providing strategies, resources and support to second-stage companies for next level growth through Strategic Research and peer-to-peer CEO mentoring, GrowFL helps companies overcome obstacles to growth and leads them towards prosperity. Based on the philosophy of Economic Gardening® — to grow existing businesses in a community, region or state — GrowFL, the Florida Economic Gardening Institute, is a critical component to the state’s economic development strategy and Florida’s entrepreneurial ecosystem. GrowFL is a statewide economic development organization certified by the National Center for Economic Gardening through the Edward Lowe Foundation. Website: growfl.com

Read more Press Releases - Biotechnology stories from the Miami Herald

  • OPKO Launches the 4Kscore Test in Europe

    OPKO Health, Inc. (NYSE:OPK) today announced the European launch of the 4Kscore ™ Test, the only blood test that accurately identifies risk for aggressive prostate cancer, through its wholly owned subsidiary, OPKO Health Spain. The launch in Europe follows the U.S. launch of the 4Kscore earlier this year.

  • Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep

    Researchers at biotech firm Morphogenesis have identified marine microorganisms that will yield critical pharmaceuticals such as anti-cancer drugs and antibiotics from seafloor sediment samples harvested by Odyssey

  • Lakewood-Amedex Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology

    /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued a 'Notice of Allowance' for patent application 11/673,486 entitled 'Oligonucleotide-Containing Pharmacological Compositions And Their Uses'.  The '486 patent application relates to the Company's orally-deliverable nanoRNA therapeutics that act through gene-silencing and can be designed to treat a wide range of chronic and acute diseases such as arthritis, inflammation, influenza, hepatitis and many other viral indications.  With this latest notice of allowance, the Company portfolio of patent in the antisense field expands to 36 on a worldwide basis with claims covering its proprietary chemistry, gene targets, and multiple indications.

Join the
Discussion

The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

The Miami Herald uses Facebook's commenting system. You need to log in with a Facebook account in order to comment. If you have questions about commenting with your Facebook account, click here.

Have a news tip? You can send it anonymously. Click here to send us your tip - or - consider joining the Public Insight Network and become a source for The Miami Herald and el Nuevo Herald.

Hide Comments

This affects comments on all stories.

Cancel OK

  • Marketplace

Today's Circulars

  • Quick Job Search

Enter Keyword(s) Enter City Select a State Select a Category